AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextCure, Inc. Director's Dealing 2020

Jun 15, 2020

Director's Dealing

Opens in your device viewer

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2020-06-11

Reporting Person: KABAKOFF DAVID S (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-11	Stock Option (Right to Buy)	$24.13	A	14250	Acquired	2030-06-10	Common Stock (14250)	Direct

F1: The option vests in full on the earlier of June 11, 2021 and the date of the 2021 Annual Meeting of Stockholders.